PT Kalbe Farma Tbk.

Rp 755.00As of Sun 8 Nov 2026, 12:00 UTC
IDX:KLBFHealthcare
Country Indonesia
PE (Fwd) •••
TSR 10Y CAGR (6.12%)
Div yield 2.65%
ROE 15.13%
Drug Manufacturers (General)
Beta (5Y) (0.05)
PE TTM 9.072
TSR TTM (39.12%)
Mkt cap Rp 34.12T
ROIC 17.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Rp 826
9.46%
46.09%
Hold 0|1|12|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareRp
11.58
12.49
12.68
12.89
31.58%
31.07%
26.74%
19.77%
RevenueRp B
4,372
4,498
4,728
4,963
10.16%
14.07%
15.58%
16.58%
Peers (US$1.885B)
Cap (US$)
PE
997.4M
12.61x
1.879B
20.53x
Capital
TTM
5Y
10Y
Leveragex
7.538
0.188
0.180
EBIT/Intx
1.080
0.149
0.169
Own earn%
(180.86)
6.45
5.33
Sh yield%
23.33
30.65
33.12
Owners
Insiders/Inst%
12.34
37.77
Short interest%
2.16
SBC / revenue%
1.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
4–13
$1 testx
−0.1
Incr. ROIC%
4